Business Context and Reporting Period
Company: IRIDEX Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: January 8, 2019
Reporting Period: Fourth quarter and full year ended December 29, 2018
Context: The filing announces preliminary, unaudited results specifically for Cyclo G6 glaucoma laser system and G6 probe shipments and revenues.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It serves as a notification that these preliminary results have been announced and are detailed in an attached press release (Exhibit 99.1).
Material Changes
The filing does not contain specific data to compare against prior periods. It references the announcement of preliminary results for the fourth quarter and full year ended December 29, 2018, but does not quantify changes within the body of this 8-K document.
Guidance, Outlook, and Risks
Management Commentary: The company announced preliminary, unaudited results for its Cyclo G6 glaucoma laser system and G6 probe.
Legal Disclaimer: The information contained in this filing is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Risks/Contingencies: No specific risks or contingencies are detailed in this summary text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 8, 2019) for the actual numerical values of shipments and revenues.
- Verify the specific breakdown of Cyclo G6 laser system versus G6 probe performance.
- Confirm if the preliminary unaudited figures differ significantly from previously issued guidance or analyst expectations.
- Check subsequent filings for the audited financial statements to reconcile with these preliminary numbers.